Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis
Authors
Keywords
Myasthenia gravis, Interleukin-21, Glucocorticoid treatment, Anti-AchR antibody
Journal
NEUROLOGICAL SCIENCES
Volume 35, Issue 1, Pages 29-34
Publisher
Springer Nature
Online
2013-05-25
DOI
10.1007/s10072-013-1460-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Ex Vivo Production of IL-6 and IL-21 by CD4+ T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients
- (2012) Ulisses C. Linhares et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Rimexolone inhibits proliferation, cytokine expression and signal transduction of human CD4+ T-cells
- (2010) Cornelia M. Spies et al. IMMUNOLOGY LETTERS
- Glucocorticosteroids Modify Langerhans Cells To Produce TGF- and Expand Regulatory T Cells
- (2010) G. Stary et al. JOURNAL OF IMMUNOLOGY
- Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients
- (2010) Masayuki Masuda et al. JOURNAL OF NEUROIMMUNOLOGY
- Increased Interleukin 21 (IL-21) and IL-23 Are Associated with Increased Disease Activity and with Radiographic Status in Patients with Early Rheumatoid Arthritis
- (2010) T. K. RASMUSSEN et al. JOURNAL OF RHEUMATOLOGY
- The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights
- (2010) Agnes E. Coutinho et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile
- (2009) Huan Yang et al. INFLAMMATION RESEARCH
- Elevated Production of B Cell Chemokine CXCL13 is Correlated with Systemic Lupus Erythematosus Disease Activity
- (2009) C. K. Wong et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
- (2009) Matthew N Meriggioli et al. LANCET NEUROLOGY
- CD4+T Cells and Cytokines in the Pathogenesis of Acquired Myasthenia Gravis
- (2008) Bianca M. Conti-Fine et al. Annals of the New York Academy of Sciences
- Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells
- (2008) Miljana Momčilović et al. BMC IMMUNOLOGY
- The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer
- (2008) Rosanne Spolski et al. CURRENT OPINION IN IMMUNOLOGY
- Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis
- (2008) Yutaka Furukawa et al. JOURNAL OF NEUROIMMUNOLOGY
- Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity
- (2007) Rosanne Spolski et al. Annual Review of Immunology
- IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis
- (2007) Ruolan Liu et al. EXPERIMENTAL NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now